View DividendRBC Bioscience マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報 最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間no dataCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間データなし経営陣の近況RBC Bioscience Corporation, Annual General Meeting, Jun 27, 2024Apr 12すべての更新を表示Recent updatesNew minor risk - Share price stability Nov 08Investor sentiment deteriorates as stock falls 15% Oct 23Investor sentiment improves as stock rises 16% Oct 08Upcoming dividend of NT$0.56 per share Sep 12Upcoming dividend of NT$0.44 per share Jul 29Full year 2023 earnings released: EPS: NT$0.50 (vs NT$0.29 in FY 2022) Apr 25RBC Bioscience Corporation, Annual General Meeting, Jun 27, 2024Apr 12New minor risk - Financial data availability Feb 27Now 23% undervalued Feb 20Now 20% undervalued Jan 22Now 21% undervalued Jan 16Now 20% undervalued Nov 29Upcoming dividend of NT$1.12 per share at 6.2% yield Jul 06Investor sentiment improves as stock rises 17% Mar 06Investor sentiment improves as stock rises 26% Feb 13Investor sentiment improved over the past week Dec 27Investor sentiment improved over the past week Apr 18CEO（最高経営責任者RBC Bioscience CEOがいない、あるいは彼らに関するデータがない。View Ownership